Among the other suggestions from the WHO, there was the proposed addition of a footnote on the Plan I section with the Conference, stating that preparations that contains predominantly cannabidiol and not in excess of 0.2 for each cent of delta-nine-tetrahydrocannabinol are certainly not under Inter